Treace Medical Concepts Inc (NASDAQ:TMCI) — Market Cap & Net Worth
Market Cap & Net Worth: Treace Medical Concepts Inc (TMCI)
Treace Medical Concepts Inc (NASDAQ:TMCI) has a market capitalization of $227.70 Million ($227.70 Million) as of June 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16144 globally and #3764 in its home market, demonstrating a 7.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Treace Medical Concepts Inc's stock price $4.01 by its total outstanding shares 64872976 (64.87 Million). Review TMCI total liabilities to assess the company's total debt and financial obligations.
Treace Medical Concepts Inc Market Cap History: 2021 to 2026
Treace Medical Concepts Inc's market capitalization history from 2021 to 2026. Data shows change from $1.21 Billion to $260.14 Million (-30.18% CAGR).
Index Memberships
Treace Medical Concepts Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.01% | #442 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #1573 of 3165 |
Weight: Treace Medical Concepts Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Treace Medical Concepts Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Treace Medical Concepts Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.75x
Treace Medical Concepts Inc's market cap is 0.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.21 Billion | $94.42 Million | -$20.55 Million | 12.81x | N/A |
| 2022 | $1.49 Billion | $141.84 Million | -$42.81 Million | 10.52x | N/A |
| 2023 | $827.13 Million | $187.12 Million | -$49.53 Million | 4.42x | N/A |
| 2024 | $482.65 Million | $209.36 Million | -$55.74 Million | 2.31x | N/A |
| 2025 | $158.94 Million | $212.69 Million | -$59.00 Million | 0.75x | N/A |
Competitor Companies of TMCI by Market Capitalization
Companies near Treace Medical Concepts Inc in the global market cap rankings as of June 19, 2026.
Key companies related to Treace Medical Concepts Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
Treace Medical Concepts Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Treace Medical Concepts Inc's market cap moved from $1.21 Billion to $ 260.14 Million, with a yearly change of -30.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $260.14 Million | +63.67% |
| 2025 | $158.94 Million | -67.07% |
| 2024 | $482.65 Million | -41.65% |
| 2023 | $827.13 Million | -44.54% |
| 2022 | $1.49 Billion | +23.34% |
| 2021 | $1.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Treace Medical Concepts Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $227.70 Million USD |
| MoneyControl | $227.70 Million USD |
| MarketWatch | $227.70 Million USD |
| marketcap.company | $227.70 Million USD |
| Reuters | $227.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more